Reclast Related Clinical Trials
Perioperative Treatment With Zoledronic Acid in Patients With Resectable Pancreas Cancer [Recruiting]
Study of Zoledronic Acid Administered Monthly Versus Every 3 Months in Multiple Myeloma and Breast Cancer Patients Who Were Treated With Zoledronic Acid the Prior Year [Recruiting]
Re-treatment of Patients With Paget's Disease Using Zoledronic Acid [Recruiting]
PET Scanning to Evaluate Zoledronate Efficacy in Metastatic Prostate Cancer [Recruiting]
Effect of Zoledronic Acid as Anti-Cancer Treatment in Metastatic Breast Cancer Patients [Recruiting]
Pilot Study of Bisphosphonate Therapy (Zoledronic Acid) in Patients With Malignant Mesothelioma (UAB 0901) [Recruiting]
Biomarkers in Tissue Samples From Patients With Newly Diagnosed Breast Cancer Treated With Zoledronic Acid [Recruiting]
Zoledronic Acid in MS-patients With Osteoporosis [Recruiting]
Dasatinib in Combination With Zoledronic Acid for the Treatment of Breast Cancer With Bone Metastasis [Recruiting]
Zoledronic Acid in Acute Spinal Cord Injury [Recruiting]
Efficacy and Safety of Zoledronic Acid in Acute Spinal Cord Injury: Prevention of Bone Loss [Recruiting]
Docetaxel and Prednisolone With or Without Zoledronic Acid and/or Strontium Chloride Sr 89 in Treating Patients With Prostate Cancer Metastatic to Bone That Has Not Responded to Hormone Therapy [Recruiting]
Impact on Reducing the Incidence of Low Serum Calcium by Providing Educational Materials on the Need to Take Daily Supplemental Calcium and Vitamin D to Patients With Paget's Disease Treated With Reclast® [Recruiting]
An Efficacy and Safety Trial of Intravenous Zoledronic Acid in Infants Less Than One Year of Age, With Severe Osteogenesis Imperfecta [Recruiting]
The Efficacy of Zoledronic Acid in Modic Changes-related Low Back Pain (LBP) [Recruiting]
Comparative Study of Neoadjuvant Chemotherapy With and Without Zometa for Management of Locally Advanced Breast Cancers [Recruiting]
Evaluation of Zoledronic Acid as a Single Agent or as an Adjuvant to Chemotherapy in High Grade Osteosarcoma [Recruiting]
Phase 1 Study of Zoledronic Acid in Sickle Cell Disease [Recruiting]
The Effect of Treatment With Teriparatide and Zoledronic Acid in Patients With Osteogenesis Imperfecta [Not yet recruiting]
Zoledronic Acid in Aromatase Inhibitor Induced Musculoskeletal Symptoms [Recruiting]
Zoledronic Acid for the Prevention of Bone Loss Post-bone Marrow Transplantation for Thalassemia Major Patients [Recruiting]
Study of Zoledronic Acid Versus Observation on Bone Mineral Density and Incidence of Micrometastasis in Women Undergoing Pelvic Radiation for Cervical Cancer [Recruiting]
Zometa Adjuvant Treatment of Malignant Pleural Effusion Due To Non-Small Cell Lung Cancer [Not yet recruiting]
Bone Loss Treatment From Adjuvant Zoledronate Efficacy [Recruiting]
Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Subjects With Multiple Myeloma [Recruiting]
Effect of the Combination of Bortezomib/Dexamethasone/Zoledronic Acid on Bone Disease in Patients With Multiple Myeloma Who Have Relapsed After 1-3 Prior Lines of Therapy [Recruiting]
Adjuvant Zoledronic Acid in High Risk Giant Cell Tumour of Bone (GCT) [Recruiting]
N2007-02:Bevacizumab,Cyclophosphamide,& Zoledronic Acid in Patients W/ Recurrent or Refractory High-Risk Neuroblastoma [Recruiting]
Zoledronate in Preventing Skeletal (Bone)-Related Events in Patients Who Are Receiving Androgen Deprivation Therapy For Prostate Cancer and Bone Metastases [Recruiting]
Efficacy and Safety of Zoledronic Acid ( Every 4 Weeks vs. Every 12 Weeks) in Patients With Documented Bone Metastases From Bone Cancer [Recruiting]
Zometa on Bone Mineral Density in Prostate Cancer Patients Undergoing Androgen Ablation Therapy [Recruiting]
Effect of Zoledronic Acid on Chemotherapy Induced Bone Loss [Recruiting]
Zometa and Circulating VEGF in Breast Cancer Patients With Bone Metastasis [Recruiting]
To Evaluate the Efficacy of ZOMETA® in Treatment of Bone Metastases in Patients With Stage IV Nasopharyngeal Cancer [Recruiting]
Postoperative Use of Zoledronic Acid in Breast Cancer Patients After Neoadjuvant Chemotherapy [Recruiting]
Zoledronic Acid (ZOMETA) With Cyclophosphamide With Neuroblastoma and Cortical Bone Involvement [Recruiting]
Efficacy in Reducing Fractures and Safety of Zoledronic Acid in Men With Osteoporosis [Recruiting]
Feasibility of Doctors' Rooms-Based Infusion of Zoledronic Acid [Recruiting]
Comparison of Zometa Retention and Effect in Multiple Myeloma and Breast Cancer [Not yet recruiting]
Multi-Center Phase II Study to Compare MER-101 20mg Tablets to Intravenous Zometa 4mg in Male Bisphosphonate-Naive, Hormone Refractory Prostate Cancer Patients [Recruiting]
Zoledronic Acid Treatment of Spontaneous Osteonecrosis of the Knee [Recruiting]
Single Dosing of Zoledronic Acid in Cancer Therapy Induced Bone Loss (CTIBL) [Recruiting]
Study of Zoledronic Acid, Pravastatin, and Lonafarnib for Patients With Progeria [Recruiting]
Zoledronic Acid Versus Alendronate for Prevention of Bone Loss After Organ Transplantation [Recruiting]
Efficacy of Zoledronic Acid in Preventing Collapse of the Osteonecrotic Femoral Head [Recruiting]
Safety and Efficacy of Zoledronic Acid in Patients With Breast Cancer With Metastatic Bone Lesions [Recruiting]
Study of IL2 in Combination With Zoledronic Acid in Patients With Kidney Cancer [Recruiting]
Zoledronate With or Without Thalidomide in Treating Patients With Early Stage Multiple Myeloma [Recruiting]
Zoledronic Acid Treatment (Every 4 or 12 Weeks) to Prevent Skeletal Complications in Advanced Multiple Myeloma Patients [Recruiting]
Using TRAP to Evaluate the Effect of Zometa on Bone Metastasis Due to Lung Cancer [Recruiting]
Safety and Efficacy Study of Concomitant Radiotherapy and Zoledronic Acid for Bone Metastases Palliation [Recruiting]
Effects of Zoledronic Acid and Raloxifene on Bone Turnover Markers in Postmenopausal Women With Low Bone Mineral Density [Recruiting]
Treatment of the Hutchinson-Gilford Progeria Syndrome With a Combination of Pravastatin and Zoledronic Acid [Recruiting]
Ibandronate or Zoledronate in Treating Patients With Newly Diagnosed Bone Metastases From Breast Cancer [Recruiting]
Investigating the Biological Effects of the Addition of Zoledronic Acid to Pre-Operative Chemotherapy in Breast Cancer [Recruiting]
Paricalcitol and Zoledronate in Treating Patients With Relapsed or Refractory Multiple Myeloma or Other Plasma Cell Disorders [Recruiting]
Investigation of Changes in Bone Scan Imaging Before and After Intravenous Bisphosphonate Therapy for Osseous Metastases From Breast Cancer [Recruiting]
A Prospective Multicentre Phase II Trial of Zoledronic Acid in Patients With Myelofibrosis With Myeloid Metaplasia (MMM) [Recruiting]
Zoledronic Acid in Preventing Osteoporosis in Patients Undergoing Donor Stem Cell Transplant [Recruiting]
A Study to Evaluate the Safety and Efficacy of Zoledronic Acid in the Prevention or Delaying of Bone Metastasis in Patients With Stage IIIA and IIIB Non-Small Cell Lung Cancer [Recruiting]
Efficacy and Safety Study of ZOMETA® in Treatment of High-level NTX Non Small Cell Lung Cancer With Bone Metastasis [Recruiting]
Study to Assess Efficacy and Safety of Zoledronic Acid and the Value of Markers of Bone Resorption in the Prediction of Bone Metastases and Cancer Treatment-Induced Bone Loss (CTIBL) in Patients With Prostate Cancer on Hormone Therapy [Recruiting]
Safety/Efficacy of Letrozole Monotherapy or in Combination With Zoledronic Acid as Extended Adjuvant Treatment of Postmenopausal Patients With Primary Breast Cancer [Recruiting]
Effects of Zoledronic Acid Versu Alendronate on Bone Loss After Kidney and Kidney/Pancreas Transplants [Recruiting]
Higher Frequency Zoledronic Acid in the Treatment of Multiple Myeloma [Recruiting]
Combination Chemotherapy With or Without Zoledronic Acid in Treating Patients With Osteosarcoma [Recruiting]
The Safety and Efficacy of Zoledronic Acid in the Prevention of Cancer Therapy Induced Bone Loss [Recruiting]
Zoledronic Acid for Osteoporosis in the Elderly [Recruiting]
Study of Zoledronic Acid for Patients With Hormone-Sensitive Bone Metastases From Prostate Cancer [Recruiting]
Zoledronate in Treating Patients With Cervical Intraepithelial Neoplasia 2/3 or 3 [Recruiting]
Long Term Efficacy and Safety of Zoledronic Acid Treatment in Patients With Bone Metastases [Recruiting]
A Study of Zoledronic Acid in the Prevention of Cancer Therapy-Induced Bone Loss [Recruiting]
Zoledronate in Preventing Osteoporosis and Bone Fractures in Patients With Locally Advanced Nonmetastatic Prostate Cancer Undergoing Radiation Therapy and Hormone Therapy [Recruiting]
Zoledronic Acid With Intermittent Hormonal Therapy in Patients With Prostate Cancer [Recruiting]
Androgen Blockade Therapy With or Without Zoledronic Acid in Treating Patients With Prostate Cancer and Bone Metastases [Recruiting]
|
